MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617060315 A) filed by Alto Neuroscience, Inc. on May 12, 2026, for Treatment Of Neuropsychiatric Disorders With Tilivapram.
Inventors include Etkin, Amit; Savitz, Adam; Wu, Wei; Jordan, Joshua Number; Sujatha Ravindran, Akshay; Morimoto, Bruce; Wang, Chao; and Sundar, Guhan.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: This invention relates to the treatment of a neuropsychiatric disorder, such as schizophrenia or Parkinson's disease, by administration (for example, transdermally) of tilivapram, zatolmilast, roflumilast, or a pharmaceutically acceptable salt thereof.
Disclaimer: Curated by HT Syndication.
